(Q36623099)

English

Prognostic impact of urokinase-type plasminogen activator receptor (uPAR) in cytosols and pellet extracts derived from primary breast tumours

scientific article published on July 2001

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Prognostic impact of urokinase-type plasminogen activator receptor (uPAR) in cytosols and pellet extracts derived from primary breast tumours (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1 reference

based on heuristic

inferred from title

author name string

de Witte JH

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Foekens JA

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Brünner N

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Heuvel JJ

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

van Tienoven T

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Look MP

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Klijn JG

7

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Geurts-Moespot A

8

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Grebenchtchikov N

9

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Benraad T

10

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Sweep CG

11

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

language of work or name

0 references

publication date

1 July 2001

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

85

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

85-92

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

copyright license

Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported

1 July 2001

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363926

30 September 2017

Prognostic value of tissue-type plasminogen activator (tPA) and its complex with the type-1 inhibitor (PAI-1) in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363926

30 September 2017

Clinical relevance of the urokinase plasminogen activator system in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363926

30 September 2017

Prognostic impact of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) in cytosols and pellet extracts derived from 892 breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363926

30 September 2017

Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363926

30 September 2017

Domain interplay in the urokinase receptor. Requirement for the third domain in high affinity ligand binding and demonstration of ligand contact sites in distinct receptor domains.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363926

30 September 2017

Regulation of integrin function by the urokinase receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363926

30 September 2017

Biology and biochemistry of proteinases in tumor invasion.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363926

30 September 2017

An alternatively spliced variant of mRNA for the human receptor for urokinase plasminogen activator

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363926

30 September 2017

The structure and function of the urokinase receptor, a membrane protein governing plasminogen activation on the cell surface.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363926

30 September 2017

Role of collagenases in tumor cell invasion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363926

30 September 2017

Plasminogen activators, tissue degradation, and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363926

30 September 2017

Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363926

30 September 2017

Plasminogen activator inhibitors: hormonally regulated serpins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363926

30 September 2017

Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363926

30 September 2017

Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363926

30 September 2017

The role of proteolytic enzymes in cancer invasion and metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363926

30 September 2017

A soluble form of the glycolipid-anchored receptor for urokinase-type plasminogen activator is secreted from peripheral blood leukocytes from patients with paroxysmal nocturnal hemoglobinuria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363926

30 September 2017

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363926

30 September 2017

The urokinase-type plasminogen activator system in cancer metastasis: A review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363926

28 June 2018

Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363926

28 June 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1054%2FBJOC.2001.1867

21 January 2018

Elevated plasma levels of urokinase plasminogen activator receptor in non-small cell lung cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/11437407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ELISA determination of soluble urokinase receptor in blood from healthy donors and cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/11437407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/11437407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of the receptor for urokinase plasminogen activator in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11437407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proteases as prognostic markers in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11437407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitation of the receptor for urokinase plasminogen activator by enzyme-linked immunosorbent assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/11437407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of the urokinase receptor as an adhesion receptor for vitronectin

1 reference

https://pubmed.ncbi.nlm.nih.gov/11437407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase receptor in breast cancer tissue extracts. Enzyme-linked immunosorbent assay with a combination of mono- and polyclonal antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/11437407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11437407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The urokinase receptor is a major vitronectin-binding protein on endothelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/11437407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/11437407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dissemination risk index based on plasminogen activator system components in primary breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11437407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ELISA for complexes between urokinase-type plasminogen activator and its receptor in lung cancer tissue extracts

1 reference

https://pubmed.ncbi.nlm.nih.gov/11437407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1054/BJOC.2001.1867

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36623099&oldid=2199109774"